IDEAYA Biosciences Inc
NASDAQ:IDYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IDEAYA Biosciences Inc
NASDAQ:IDYA
|
US |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
C
|
Compass Group PLC
OTC:CMPGF
|
UK |
|
Alamtri Resources Indonesia Tbk PT
F:A640
|
ID |
Intrinsic Value
Is IDYA undervalued or overvalued?
See the intrinsic value estimate for
IDEAYA Biosciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
IDYA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with IDYA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What IDEAYA Biosciences Does
IDEAYA Biosciences is a biotechnology company that develops cancer drugs aimed at tumors with specific genetic weaknesses. Its work focuses on precision oncology, especially small-molecule medicines designed to block the pathways cancer cells depend on while sparing healthier cells. The company’s main assets are its drug candidates and the science behind matching the right drug to the right tumor type.
- Headquarters
- United States of America US
- Employees
- 145
- IPO date
- May 23, 2019
Revenue & Expenses Breakdown
IDEAYA Biosciences Inc
Earnings Waterfall
IDEAYA Biosciences Inc
The intrinsic value for
IDEAYA Biosciences Inc (IDYA) under the Base Case is hidden USD.
Compared with the current market price of 32.85 USD, the stock appears hidden.